![Petter Veiby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 $ al 31/07/2026
Petter Veiby is the founder of Attovia Therapeutics, Inc., founded in 2022, serving as Chief Scientific Officer.
Mr. Veiby is currently Director at BiVictriX Therapeutics Plc since 2025.
Former jobs include Senior Director at Millennium Pharmaceuticals, Inc. from 2022 to 2023, Global Head-Biotherapeutics at Millennium Pharmaceuticals, Inc. from 1999 to 2020, and Senior Vice President-Business Development at Immunitas Therapeutics, Inc. in 2022.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/08/2026 | 104.952 ( 0,24 % ) | 1 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Fundador | 16/12/2022 |
| BIVICTRIX THERAPEUTICS PLC | Director/Miembro de la Junta | 01/08/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/06/2023 |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Corporate Officer/Principal | 01/11/2022 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/03/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
BiVictriX Therapeutics Plc
 BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Attovia Therapeutics
 Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
